Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S

NCT03615911 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

MERS (Middle East Respiratory Syndrome)

Interventions

BIOLOGICAL: vaccine candidate MVA-MERS-S

Sponsor

Marylyn Addo

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]